Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 200Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2ABBVIE

02 10NOVARTIS

03 33NOVARTIS PHARMS CORP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioFlorida Conference
Not Confirmed

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

US Patent Number : 7838552

Drug Substance Claim :

Drug Product Claim :

Application Number : 206302

Patent Use Code : U-185

Delist Requested :

Patent Use Description : METHOD OF TREATING HYP...

Patent Expiration Date : 2027-10-04

Abbvie Company Banner

02

arrow
BioFlorida Conference
Not Confirmed

NEBIVOLOL HYDROCHLORIDE; VALSARTAN

US Patent Number : 7803838

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 206302

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-08-29

Abbvie Company Banner

03

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 9388134

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-1723

Delist Requested :

Patent Use Description : TREATMENT OF HEART FAI...

Patent Expiration Date : 2026-11-08

blank

04

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 9388134

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-1723

Delist Requested :

Patent Use Description : TREATMENT OF HEART FAI...

Patent Expiration Date : 2026-11-08

blank

05

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 11135192

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-3084

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-22

blank

06

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 11135192

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-3084

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-22

blank

07

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 11135192

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-3084

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-22

blank

08

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 9517226

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-3084

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-22

blank

09

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 9937143

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-3084

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-22

blank

10

arrow
BioFlorida Conference
Not Confirmed
arrow
BioFlorida Conference
Not Confirmed

SACUBITRIL; VALSARTAN

US Patent Number : 9517226

Drug Substance Claim :

Drug Product Claim :

Application Number : 207620

Patent Use Code : U-3084

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-08-22

blank